Tyra Biosciences, Inc.
TYRANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $1.26B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $13.35$40.65
- Volume (live)
- -
- Avg. volume (3M)
- 1.19M
Tyra Biosciences (TYRA) Stock Price & Financial Analysis
Tyra Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $18.26 - $19.09 |
|---|---|
| 52-Week High | $40.65 |
| 52-Week Low | $13.35 |
| Open | $19.09 |
| Volume (last close) | 648.97K |
| Average Volume (3M) | 1.19M |
| 50-Day MA | $23.98 |
|---|---|
| 200-Day MA | $30.31 |
| 1-Year Change | +31.31% |
| Market Cap | 1.26B |
|---|---|
| Shares Outstanding | 65.99M |
| Price to Book (P/B) | 3.55 |
| EV/EBITDA | -7.84 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Tyra Biosciences at a Glance
As of the Oct 16, 2026 close, Tyra Biosciences (TYRA) has a market capitalization of $1.26B.
As of its latest reported balance sheet, it holds $73.83M in cash and securities against $5.58M of debt, a net cash position of $68.25M.
Tyra Biosciences does not currently pay a dividend.
The share price is up 31.3% over the past year. At $18.52 (the Oct 16, 2026 close) it sits within its 52-week range of $13.35 to $40.65, below its 200-day moving average of $30.31.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $47.40, 155.9% above the Oct 16, 2026 close.
Frequently Asked Questions About Tyra Biosciences
What is the current stock price for TYRA?
As of the Oct 16, 2026 close, TYRA stock trades at $18.52. The 52-week range is $13.35–$40.65, with a day range of $18.26–$19.09.
What is the P/E ratio for TYRA?
The P/E ratio (Price-to-Earnings) for TYRA is shown in the Key Statistics section. This valuation metric helps compare Tyra Biosciences, Inc. to industry peers.
Does TYRA pay dividends?
Tyra Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TYRA?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for TYRA is Buy. The average 12-month price target is $47.40, a 155.9% upside from the Oct 16, 2026 close of $18.52.
What is the market cap of TYRA?
As of the Oct 16, 2026 close, Tyra Biosciences's market capitalization is $1.22B, classifying it as a small-cap company. Tyra Biosciences operates in the Healthcare sector within the Biotechnology industry.